Buyer Database · Buyer / Distributor · Updated
Imax
Imax is a licensing-focused premium-format network operating on an asset-light model, attracting renewed Wall Street attention after box office performance surpassed pre-pandemic levels and a Goldman Sachs upgrade flagged the company as an attractive potential M&A target.
Current mandate
Imax is currently consolidating its position as the dominant premium large-format brand, with Goldman Sachs analyst Stephen Laszczyk upgrading shares to neutral from sell and raising his price target to $34 from $22 in a Nov. 25 report, citing the company's ability to leverage industry relationships and programming flexibility to take box office market share. Laszczyk explicitly characterized Imax as an attractive potential M&A target and a "relatively easy media asset to operate," a framing that has sharpened industry focus on the company's strategic value. Imax shares rose 2.3 percent to $36.83 following the note.
Over the past twelve months, Imax has driven performance through four distinct levers: better indexing, growth in international and local-language box office contribution, expansion of its screen install base (including seven new Imax with Laser theaters in Japan announced for delivery by summer 2023), and greater studio-funded marketing. The company does not generate its own IP or maintain physical infrastructure, operating instead on a licensing model with low net leverage. That structure has allowed it to recover margins to pre-pandemic levels even as the broader domestic box office remained constrained.
For filmmakers and rights holders, the practical access point runs through Imax's studio partnerships and its programming team rather than through any direct script-acquisition pipeline. Imax does not acquire scripts or produce originals; its leverage over a film's commercial trajectory comes at the exhibition and licensing stage, making studio relationships and format-compatibility the primary variables for any project seeking an Imax release window.
Signature peaks
- 7 new theaters Screen Expansion — Imax with Laser locations added in Japan, targeted by summer 2023
- +2.3% Share Price Move — Imax shares rose 83 cents to $36.83 on Goldman upgrade note
- 30 Decision Makers Tracked — Tracked contacts across Imax organization per ScriptMatch data
Mandate dimensions
- Genre focus
- Not disclosed
- Territory focus
- Not disclosed
- Budget tier (observed)
- Not disclosed
- Access pattern
- Access runs through Imax's studio and programming relationships rather than any direct submission channel. Imax does not acquire scripts or produce originals. Projects seeking Imax format placement should secure studio or major distributor attachment first, then engage Imax's programming team through that partner relationship. ScriptMatch tracks 30 decision makers within the Imax organization, with signals as recent as June 2026.
- Deal structure
- Imax operates on a licensing model with low net leverage and no reliance on physical infrastructure ownership, per Goldman Sachs analyst Stephen Laszczyk. It does not co-produce or finance films. Format agreements are typically negotiated at the studio level, covering premium screen allocation and Imax-specific marketing contributions. No specific deal terms or fee structures were disclosed in available coverage.
Recent acquisitions
-
Seven new Imax with laser theaters in Japan
-
Two new locations outside Tokyo and Osaka
Market context
"We are not an exhibitor." — CEO Rich Gelfond, positioning Imax to Wall Street analysts
Imax is currently consolidating its position as the dominant premium large-format brand, with Goldman Sachs analyst Stephen Laszczyk upgrading shares to neutral from sell and raising his price target to $34 from $22 in a Nov. 25 report, citing the company's ability to leverage industry relationships and programming flexibility to take box office market share. Laszczyk explicitly characterized Imax as an attractive potential M&A target and a "relatively easy media asset to operate," a framing that has sharpened industry focus on the company's strategic value. Imax shares rose 2.3 percent to $36.83 following the note.
Common questions about Imax
Does Imax accept unsolicited scripts?
No. Imax does not acquire scripts or develop original IP. Its licensing-focused, asset-light operating model means it does not function as a traditional production company or studio. Imax's role in a film's life cycle begins at the exhibition and format-licensing stage. Writers and producers seeking an Imax release should work through a studio or distributor that already has an established relationship with Imax's programming team, as that is the operative access channel.
What budgets does Imax typically work with?
Imax does not attach to projects at the financing stage and does not publish budget thresholds for format eligibility. Historically, Imax releases have skewed toward large-scale studio tentpoles where the premium format can justify higher ticket prices and where studios are willing to fund Imax-specific marketing, a factor Goldman Sachs analyst Stephen Laszczyk cited as a key driver of Imax's recovered box office performance. Budget figures for specific recent deals were not disclosed in available coverage.
Does Imax have a presence at film festivals?
Imax's programming activity is oriented around commercial theatrical release windows rather than festival acquisition. The company's deal flow runs through its studio and exhibitor relationships. There is no documented pattern in recent coverage of Imax using festivals as a primary acquisition or programming venue. Projects that premiere at festivals and subsequently attract studio distribution deals may eventually reach Imax screens, but that pathway runs through the studio partner, not directly through Imax.
How do you reach Imax's programming or acquisitions team?
Imax maintains 30 tracked decision makers across its organization per ScriptMatch data, with the latest signal recorded in June 2026. Because Imax does not acquire scripts or produce originals, the relevant contacts are on the programming and studio-relations side rather than in a traditional acquisitions department. Industry coverage consistently points to studio partnerships as the primary channel. Direct outreach is most productive when a project already has studio or major distributor attachment.
What genres is Imax focused on right now?
Imax's format is best suited to visually immersive, large-scale productions, and its recent box office recovery has been driven in part by growth in international and local-language content alongside Hollywood tentpoles, according to Goldman Sachs analyst Stephen Laszczyk. The company's programming flexibility, which Laszczyk credited as a key competitive advantage, suggests it is not rigidly genre-locked, but action, sci-fi, and event films with strong visual scope remain the core of its commercial slate based on available coverage.
Is Imax currently active as a buyer or distributor?
Imax is active as a premium-format licensor and exhibitor network, not as a traditional film buyer or distributor. Its 41 tracked records over the past 12 months and 30 monitored decision makers indicate ongoing industry engagement. Recent expansion activity includes seven new Imax with Laser theaters in Japan announced for delivery by summer 2023, and two additional locations outside Tokyo and Osaka announced at CinemaCon in April 2022. The company's deal velocity and M&A profile have drawn heightened analyst attention as of late 2023.
Adjacent buyers in this lane
- Focus Features — Focus Features is doubling down on experiential brand-building and festival acquisitions to court th
- Roadside Attractions — Roadside Attractions is a North American boutique distributor actively acquiring festival-originated
- Fox Entertainment — Fox Entertainment is running a deliberate, low-volume acquisition strategy built around creator-led,
- 20th Television — 20th Television is actively building its overall-deal roster and deepening its animation pipeline, w
Related reading
Match your script to Imax
This is a public snapshot of Imax, kept current from trade-press signals. Inside ScriptMatch, upload your script to see whether Imax fits, why, and exactly how to reach them. Start a free 7-day trial or try the free buyer-match tool.